635 articles in this topic
Small pilot study examined psilocybin's effects on brain circuits and emotion processing in healthy adults to understand abuse potential.
French pilot study tests psychedelic therapy for patients with alcohol use disorder and comorbid depression after withdrawal.
Small doses of psilocybin tested against placebo in 39 adults with major depressive disorder to assess safety and mood benefits.
Small trial tests psychedelic therapy combined with meditation for frontline healthcare providers suffering COVID-related burnout.
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Three existing drugs, including a shingles vaccine, emerge as top candidates for repurposing against Alzheimer's disease.
Study tested whether pimavanserin could prevent return of hallucinations and delusions in dementia patients who initially responded to treatment.
New digital education program targets lifestyle factors like diet and exercise to reduce cognitive decline risk in older adults.
USC researchers discover people with Down syndrome and Alzheimer's have twice the brain iron levels, triggering damaging cell death.
Brown University research reveals ChatGPT and similar AI systems break 15 ethical standards when used for therapy advice.
King's College study tests whether simple chewing and fasting patterns can enhance cognitive function and neurogenesis in older adults.
New research reveals intelligence comes from how efficiently brain networks communicate together, not from one 'smart' brain area.
